HRT Financial’s Exelixis EXEL Stock Holding History

HRT Financial’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,300	Closed	-$889K	–	4066
2025 Q4	$889K	Buy	+20,300	New	+$840K	﹤0.01%	1788

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's EXEL Position: Q2 2026 in Review

HRT Financial increased its Exelixis (EXEL) stake by 102% in Q2 2026, buying an estimated $22.8M and bringing the position to 929,242 shares worth $50.6M. The position accounts for 0.09% of the portfolio, ranked #197.

HRT Financial first reported a position in EXEL in Q2 2015 and has held it in 20 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

HRT Financial held 929,242 shares of Exelixis worth $50.6M as of Q2 2026.
HRT Financial bought 468,657 Exelixis shares in Q2 2026, an estimated $22.8M.
Exelixis made up 0.09% of HRT Financial's portfolio in Q2 2026, its #197 holding.
HRT Financial first reported a position in Exelixis in Q2 2015 and has held it in 20 quarters since.
758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.